Karthik Devarajan

Karthik Devarajan

Temple University

H-index: 38

North America-United States

About Karthik Devarajan

Karthik Devarajan, With an exceptional h-index of 38 and a recent h-index of 23 (since 2020), a distinguished researcher at Temple University, specializes in the field of Statistical machine learning, computational statistics, bioinformatics, survival analysis, biostatistics.

His recent articles reflect a diverse array of research interests and contributions to the field:

TET1 and TDG suppress inflammatory response in intestinal tumorigenesis: implications for colorectal tumors with the CpG Island Methylator Phenotype-virtual

Novel biomarkers that predict response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Molecular investigation of a polymorphic variant in JMJD1C that associates with chemoradiotherapy outcomes in locally advanced rectal and head and neck cancer

Smoking history is associated with reduced efficacy of neoadjuvant therapy in pancreatic adenocarcinoma

A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors

Folic Acid Supplementation Promotes Hypomethylation in Both the Inflamed Colonic Mucosa and Colitis-Associated Dysplasia

Abstract PR013: Association of a polymorphic variant in JMJD1C with response to chemoradiotherapy in rectal cancer and head and neck cancer: Implications for a diverse population

1173 OPTIMAL TIME TO SURGERY AFTER NEOADJUVANT THERAPY IN PANCREATIC ADENOCARCINOMA: IS THERE AN IDEAL WINDOW?

Karthik Devarajan Information

University

Position

Associate Professor Fox Chase Cancer Center

Citations(all)

6138

Citations(since 2020)

2583

Cited By

4805

hIndex(all)

38

hIndex(since 2020)

23

i10Index(all)

76

i10Index(since 2020)

62

Email

University Profile Page

Temple University

Google Scholar

View Google Scholar Profile

Karthik Devarajan Skills & Research Interests

Statistical machine learning

computational statistics

bioinformatics

survival analysis

biostatistics

Top articles of Karthik Devarajan

Title

Journal

Author(s)

Publication Date

TET1 and TDG suppress inflammatory response in intestinal tumorigenesis: implications for colorectal tumors with the CpG Island Methylator Phenotype-virtual

Gastroenterology

Rossella Tricarico

Jozef Madzo

Gabrielle Scher

Maya Cohen

Jaroslav Jelinek

...

2023/5/1

Novel biomarkers that predict response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Cancer Research

Adria Hasan

Elena V Demidova

Philip Czyzewicz

Karthik Devarajan

Margret B Einarson

...

2024/3/22

Molecular investigation of a polymorphic variant in JMJD1C that associates with chemoradiotherapy outcomes in locally advanced rectal and head and neck cancer

Cancer Research

Adria Hasan

Elena V Demidova

Philip Czyzewicz

Shreya M Shah

Karthik Devarajan

...

2024/3/22

Smoking history is associated with reduced efficacy of neoadjuvant therapy in pancreatic adenocarcinoma

Journal of Gastrointestinal Surgery

Rita C Akumuo

Sai P Reddy

Caroline Westwood

Karthik Devarajan

Dany Barrak

...

2024/1/23

A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors

Nature Communications

Matthew Zibelman

Alexander W MacFarlane IV

Kimberly Costello

Thomas McGowan

John O’Neill

...

2023/7/27

Folic Acid Supplementation Promotes Hypomethylation in Both the Inflamed Colonic Mucosa and Colitis-Associated Dysplasia

Cancers

Wen-Chi L Chang

Jayashri Ghosh

Harry S Cooper

Lisa Vanderveer

Bryant Schultz

...

2023/5/27

Abstract PR013: Association of a polymorphic variant in JMJD1C with response to chemoradiotherapy in rectal cancer and head and neck cancer: Implications for a diverse population

Cancer Epidemiology, Biomarkers & Prevention

Adria Hasan

Elena Demidova

Philip Czyzewicz

Shreya Shah

Karthik Devarajan

...

2023/12/1

1173 OPTIMAL TIME TO SURGERY AFTER NEOADJUVANT THERAPY IN PANCREATIC ADENOCARCINOMA: IS THERE AN IDEAL WINDOW?

Gastroenterology

Andrew B Crocker

Leah Winer

Eileen A O'Halloran

Dany Barrak

Karthik Devarajan

...

2023/5/1

Type of neoadjuvant treatment strategy is associated with differential pathologic responses in pancreatic ductal adenocarcinoma

The American Journal of Surgery

Rita C Akumuo

Anthony M Villano

Sai P Reddy

Karthik Devarajan

Dany Barrak

...

2023/11/8

1180 SMOKING HISTORY IS ASSOCIATED WITH REDUCED EFFICACY OF NEOADJUVANT THERAPY IN PANCREATIC ADENOCARCINOMA

Rita Akumuo

Sai Reddy

Karthik Devarajan

Dany Barrak

Jason Castellanos

...

2023/5/1

Prevalence and Predictors of Sexual Dysfunction (SD) after Treatment of Localized Rectal and Anal Cancer (LRAC)

International Journal of Radiation Oncology, Biology, Physics

HN Yankey

MD Lopez

K Devarajan

R Gleason

AK Pirlamarla

...

2023/10/1

Abstract PO-032: Association of a polymorphic variant in JMJD1C with tumor recurrence after adjuvant chemoradiation therapy in head and neck squamous cell …

Clinical Cancer Research

Adria Hasan

Elena V Demidova

Shreya M Shah

Philip Czyzewicz

Karthik Devarajan

...

2023/9/15

Correction to: Thymine DNA glycosylase as a novel target for melanoma

Oncogene

Pietro Mancuso

Rossella Tricarico

Vikram Bhattacharjee

Laura Cosentino

Yuwaraj Kadariya

...

2022/6

Harnessing choice architecture in urologic practice: Implementation of an opioid-sparing protocol grounded in cognitive behavioral theory

Urologic Oncology: Seminars and Original Investigations

Adrien N Bernstein

Alex Nourian

Marshall Strother

Allwin Lobo

Karthik Devarajan

...

2022/3/1

A phase I/II study of nivolumab and axitinib in patients with advanced renal cell carcinoma.

Matthew R Zibelman

Michael Anthony Carducci

Yasser Ged

Ana M Molina

Rahul Ravilla

...

2022/2/20

Elaboration Models with Symmetric Information Divergence

International Statistical Review

Majid Asadi

Karthik Devarajan

Nader Ebrahimi

Ehsan Soofi

Lauren Spirko‐Burns

2022/12

MA04. 08 The Effect of Packed Red Blood Cell Transfusions on the Clinical Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology

C D'Avella

K Devarajan

J Helstrom

M Edelman

D Geynisman

2021/3/1

A statistical framework for non-negative matrix factorization based on generalized dual divergence

Neural Networks

Karthik Devarajan

2021/8/1

Abstract PS8-16: Differences in the benefit of multi-gene panel (MGP) genetic testing between African American and white women with invasive breast cancer

Cancer Research

Kristen Whitaker

Nicole Ventriglia

Karthik Devarajan

Elias Obeid

2021/2/15

Combined inhibition of AKT and KIT restores expression of programmed cell death 4 (PDCD4) in gastrointestinal stromal tumor

Cancers

Marya Kozinova

Shalina Joshi

Shuai Ye

Martin G Belinsky

Dinara Sharipova

...

2021/7/23

See List of Professors in Karthik Devarajan University(Temple University)

Co-Authors

H-index: 140
Andrew K. Godwin, PhD

Andrew K. Godwin, PhD

University of Kansas

H-index: 112
Joseph R. Testa

Joseph R. Testa

Temple University

H-index: 84
Jonathan Chernoff

Jonathan Chernoff

Temple University

H-index: 80
Erica Golemis

Erica Golemis

Temple University

H-index: 56
Alexander Kutikov, MD, FACS

Alexander Kutikov, MD, FACS

Temple University

H-index: 47
Siddharth Balachandran

Siddharth Balachandran

Temple University

academic-engine